Abstract:Objective:To investigate the influence factors of allograft acute rejection (AR) at the metaphase and long-term after kidney transplantation and the postoperative survival of allograft.Methods:The clinical data were retrospectively analysed in 43 recipients who accepted kidney transplantation were more than 1 years and were diagnosed with AR by allograft renal biopsy during January 2018 to December 2019. Seventeen of them with acute antibody-mediated rejection were as acute antibody rejection group, 26 of them with acute T cell-mediated rejection were as acute T cell rejection group, and 39 recipients who got kidney transplantation during the same period (in 2 weeks) were matched as control group. Paired sample t test or one-way ANOVA was used to compare the measurement data conforming to normal distribution among multiple groups. Chi-square test or Fisher exact probability was used for comparison between counting data groups. Kaplan-Meier was used for survival analysis and log-rank was used for comparison. A P<0.05 was considered statistically significant.Results:The proportion of 2 mismatches at HLA-A sites in HLA match before operation (4/17) was more higher in acute antibody rejection group than that in control group (1/39), and the difference was statistically significant (P=0.026). Serum creatinine and estimated glomerular filtration rate (eGFR) at the onset and last time of AR were higher in acute antibody rejection group and acute T cell rejection group than those before AR (all P<0.05). Serum creatinine and eGFR at the onset and last time of AR in acute antibody rejection and acute T cell rejection group were higher than those in control group (all P<0.05). The proportion of chronic kidney disease (CKD)-4 recipients in acute antibody rejection group was lower than that in acute T cell rejection group (χ2=5.73, P<0.05). The proportion of CKD-4 recipients in acute T cell rejection group and the proportion of renal allograft failure in acute antibody rejection group were higher than those in control group (χ2=17. 727 and 9.882, all P<0.05). When AR happened, the rate of PRA-Ⅰ positive recipients [41.2% (7/17)] and the rate of PRA-Ⅱ positive recipients [88.2% (15/17)] in acute antibody rejection group were both higher than those in acute T cell rejection group [11.5% (3/26) and 26.9% (7/26), respectively], the difference had statistical significance (P=0.042, P<0.001). The serum concentration of tacrolimus was significantly decreased in the acute antibody rejection group (3.72±0.76) ng/mL and in the acute T cell rejection group (3.37±0. 86) ng/mL when the AR occurred, which were all lower than that of the control group (5.73±1.25) ng/mL, the difference had statistical significance (all P<0.05), and also lower than the serum concentration of tacrolimus before AR occurred, the difference had statistical significance (t=7.120 and 6.216, all P<0.05). There were 4 recipients in the acute T cell rejection group used cyclosporine, and the serum concentration of cyclosporine of 3 recipients among them was not up to the mark at 33 (112.4 ng/mL), 36 (138.3 ng/mL) and 55 (7.0 ng/mL) months after transplantation. The serum concentration of cyclosporine of 2 recipients who used cyclosporine in the acute T cell rejection group was 43.2 (16 months after transplantation) and 24.6 ng/mL (177 months after transplantation), which were not up to the mark. All the recipients were followed up until June 30, 2021, the survival rate of transplant kidney of the acute antibody rejection group was lower than the control group (χ2=8.738, P<0.05).Conclusions:Mismatch at the HLA-A sites and the lower serum concentration of tacrolimus were the important factors for inducing AR in the metaphase and long-term after kidney transplantation. Acute antibody-mediated rejection was the important factor that affected the survival of transplant kidney.

Evaluation on the Interrelationship Between Serum Spta1 Level and Allograft Acute Rejection in Living-Related Small Bowel Transplantation

Relationship Between the Expressions of Intercellular Adhesion Molecule 1, Heat Shock Protein 70 and Acute Rejection after Pancreas Allotransplantation in Miniature Swine

Evaluation of perioperative serum cytokine level in acute rejection in human living-related small bowel transplantation

THE VARIATION OF T CELL SUBSETS、 TUMOR NECROSIS FACTOR-α AND INTERLEUKIN 2 IN PANCREATIC DUODENAL ALLOTRANSPLANTATION WITH MINIATURE SWINE

Serum IL-8 levels correlate with acute rejection in recipient with human living-related small bowel transplantation

Acute rejection episodic outcomes resulted from pre-transplant serum level of the soluble CD30 in kidney transplant recipients

Diagnosis and Treatment of Acute Rejection in the First Case of Human Living-Related Small Bowel Transplantation with a Long-Term Survival in China

Experimental Study on Marker of Early Rejection in Small Bowel Transplantation

The Expression of Heat Shock Protein 70 and Its Early Diagnostic Significance in Acute Allograft Rejection of Liver-Transplanted Rats

IMPACT OF PRE-TRANSPLANT SERUM LEVELS OF IP-10,MIG AND BLC ON ACUTE REJECTION EPISODE

Clinical study on allograft acute rejection at metaphase and long-term after kidney transplantation

Acute Rejection and Cytokine after Donor-derived Bone Marrow Infusion via Portal Vein Administration in Rats Undergoing Heretotopic Small Bowel Transplantation

Association of Pre-Transplant Serum Level of Anti-Endothelial Cell Antibody with Acute Rejection in Kidney Transplant Recipients

Effect of acute humoral rejection on renal allograft survival

Role of CD4+ and CD8+ T cells in early and late acute rejection of small bowel allograft

Correlation Between Serum Level of Soluble CD30 and Panel of Reactivity Antibodies Before Operation and Early Acute Rejection after Renal Transplantation

Timing and Diagnostic Value of Endoscopic Biopsy of Intestinal Graft after Small Bowel Transplantation

Morphologic Evaluation of Biopsy Specimens on Patients with Small Bowel Allotransplantation: Singlecenter Experience

Study on the Inspection and Significance of Serum Soluble Interleukin-2 Receptor and Interleukin-6 Level in Bile after Liver Transplantation

Relationship between acute rejection in kidney transplantation and expression of sCD30

The experimental research on the perforin and granzyme B expressions to the early diagnostic value of acute rejection response after pancreatic transplantation]